NCT00046852View on ClinicalTrials.gov

Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2001

Primary Completion Date

November 30, 2004

Study Completion Date

February 29, 2008

Conditions
InfectionMultiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

pneumococcal polyvalent vaccine

BIOLOGICAL

therapeutic autologous lymphocytes

BIOLOGICAL

therapeutic tumor infiltrating lymphocytes

DRUG

carmustine

DRUG

cyclophosphamide

DRUG

melphalan

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (2)

21201

Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

19104-4283

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

University of Maryland Greenebaum Cancer Center

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT00046852 - Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter